Dix, Daniel B.,Dix, Daniel B.,Tang, Xiaolin,Tang, Xiaolin
申请号：
HRP20181822
公开号：
HRP20181822T1
申请日:
2018.10.31
申请国别(地区):
HR
年份:
2018
代理人:
摘要：
The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human interleukin-4 receptor (hIL-4R). The formulations may contain, in addition to an anti-hIL-4R antibody, at least one amino acid, at least one sugar, or at least one non-ionic surfactant. The pharmaceutical formulations of the present invention exhibit a substantial degree of antibody stability after storage for several months.
